Laryssa Wozniak

Bio:

Laryssa Wozniak is a forward-thinking biopharmaceutical leader with a laser focus on shaping commercial strategy, market entry, and product lifecycle management. With over two decades of experience across rare disease, neurology, and immunology therapeutic areas among others, Laryssa is an expert in global marketing and commercial development, and is known for creating effective pre-commercial strategies. She has developed a reputation for bridging clinical, regulatory, and commercial functions to accelerate business growth and drive corporate expansion.

Laryssa most recently served as Senior Director, Global Marketing at Immunovant where she led commercialization efforts for late-state neurological assets. Her prior roles include pre-commercialization, launch and inline accountabilities at companies spanning the growth spectrum including: Ocugen, Pfizer, GSK, Forest Laboratories & ViroPharma. She obtained her MBA with concentrations in Pharmaceutical Management and Marketing from Rutgers Business School and an undergraduate business degree from Boston University’s Questrom School of Business.